Did you mean: Watson Pharmaceuticals Inc ?

en.wikipedia.org/wiki/Actavis

Actavis Generics is a global pharmaceutical company focused on acquiring, developing, ... In 1993, Actavis, then Watson, announced its initial public offering (IPO) of shares of common stock. ... In 2000, the company acquired Schein Pharmaceutical Inc, an acquisition that more than doubled the company's size. In that same ...

www.allergan.com/news/news/thomson-reuters/watson-pharmaceuticals-inc-is-now-actavis-inc

Jan 24, 2013 ... PARSIPPANY, N.J. , Jan. 24, 2013 /PRNewswire/ -- Watson Pharmaceuticals, Inc . today announced that the company has adopted Actavis, Inc.

www.policymed.com/2018/02/watson-pharmaceuticals-now-part-of-teva-to-pay-33-million-to-mississippi.html

On January 29, 2018, Mississippi Attorney General Jim Hood announced a $33 million settlement with pharmaceutical manufacturer, Watson, Inc., which is now ...

www.drugs.com/manufacturer/watson-pharmaceuticals-inc-150.html

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products.

www.tevapharm.com

At Teva Pharmaceutical Industries, we improve people's health through our products, integrated R&D, generic medicines and global businesses.

www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=966196

Jul 9, 2018 ... Watson Laboratories, Inc. manufactures pharmaceutical drugs. The company was incorporated in 1992 and is based in Corona, California.

www.biospace.com/employer/535244/watson-pharmaceuticals-inc-

jobs with Watson Pharmaceuticals, Inc. to view and apply for now with BioSpace.

www.ftc.gov/enforcement/cases-proceedings/1210132/watson-pharmaceuticals-actavis-inc

Dec 18, 2018 ... The FTC required Watson Pharmaceuticals, Inc. and Actavis Inc. to sell the rights and assets to 18 drugs to Sandoz International GmbH and Par ...

www.bionity.com/en/companies/23078/watson-pharmaceuticals-inc.html

Watson Pharmaceuticals, Inc. is a global leader in the development and distribution of pharmaceuticals with a broad portfolio of generic products and a ...